A. Cordi
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
-
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
Papers in
-
- Receptor Mechanisms and Signaling 4
- Chemical Synthesis and Analysis 2
-
- Neuroscience and Neuropharmacology Research 4
- Co-authors
- Christian Carpéné (1 shared paper)David Nutt (1 shared paper)Alan L. Hudson (1 shared paper)Anne Rémaury (1 shared paper)Max Lafontan (1 shared paper)Nancy M. Gray (3 shared papers)Joseph B. Monahan (3 shared papers)Michael S. Dappen (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (2 papers)European Neuropsychopharmacology (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Neuropharmacology (1 paper)Cephalalgia (1 paper)
- Partner nations
- FranceUnited StatesNetherlands
In The Last Decade
A. Cordi
15 papers receiving 339 citations
Peers
Comparison fields: 5 of 67
- Biological Psychiatry 29
- Cellular and Molecular Neuroscience 199
- Behavioral Neuroscience 33
- Biochemistry 22
- Molecular Biology 189
Countries citing papers authored by A. Cordi
This map shows the geographic impact of A. Cordi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Cordi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Cordi more than expected).
Fields of papers citing papers by A. Cordi
This network shows the impact of papers produced by A. Cordi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Cordi. The network helps show where A. Cordi may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Cordi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 88 | |
| 2 | S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine. | 2000 | 77 |
| 3 | 1991 | 39 | |
| 4 | Anticonvulsant activity of milacemide. | 1983 | 35 |
| 5 | 1996 | 32 | |
| 6 | 1995 | 26 | |
| 7 | 1992 | 15 | |
| 8 | 1993 | 12 | |
| 9 | 1997 | 11 | |
| 10 | 2004 | 8 | |
| 11 | 2002 | 8 | |
| 12 | 2000 | 6 | |
| 13 | Synthesis of 1,2-diacyl-3-nicotinoyl glycerol derivatives and evaluation of their acute effects on plasma lipids in the rat. | 1995 | 1 |
| 14 | 2001 | 1 | |
| 15 | 1996 | 1 |
About A. Cordi
A. Cordi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Organic Chemistry, Physiology and Psychiatry and Mental health, having authored 15 papers that have together received 360 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (4 papers), Receptor Mechanisms and Signaling (4 papers), Nitric Oxide and Endothelin Effects (3 papers), Organic Chemistry Cycloaddition Reactions (2 papers), Chemical Synthesis and Analysis (2 papers), Synthesis and Biological Evaluation (2 papers), Click Chemistry and Applications (1 paper) and Amino Acid Enzymes and Metabolism (1 paper). The work is most often cited by research in Biological Psychiatry (29 citations), Cellular and Molecular Neuroscience (199 citations), Behavioral Neuroscience (33 citations), Biochemistry (22 citations) and Molecular Biology (189 citations). A. Cordi has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include Christian Carpéné, David Nutt, Alan L. Hudson, Anne Rémaury, Max Lafontan, Nancy M. Gray, Joseph B. Monahan, Michael S. Dappen, J. Roba and Alain P. Gobert. Their work appears in journals such as Journal of Medicinal Chemistry, European Neuropsychopharmacology, Journal of Pharmacology and Experimental Therapeutics, Neuropharmacology and Cephalalgia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.